Lichen scrofulosorum in a patient with lepromatous leprosy after BCG immunotherapy

Leprosy Review

Volumn 76, Issue 2, 2005, Pages 170-174

  Kumaran, Muthu Sendhil ^a   Dogra, Sunil ^a   Kaur, Inderjeet ^a   Kumar, Bhushan ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ADULT; BCG VACCINATION; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONFERENCE PAPER; FAMILY HISTORY; HISTOPATHOLOGY; HUMAN; IMMUNOTHERAPY; LEPROMATOUS LEPROSY; LICHEN SCROFULOSORUM; LICHENOID ERUPTION; MALE; MULTIBACILLARY LEPROSY; TUBERCULID; TUBERCULIN TEST;

ADULT; BCG VACCINE; BIOPSY, NEEDLE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; LEPROSY, LEPROMATOUS; MALE; RISK ASSESSMENT; TUBERCULOSIS, CUTANEOUS;

EID: 22844434742     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Evans RG, Warner J. Lichen scrofulosorum following BCG. Arch Dis Child, 1967; 42: 448.
2. Warner J. Lichen scrofulosorum following BCG. Br J Dermatol, 1966; 78: 549.
3. Krone C. Lichen scrofulosorum and BCG vaccination. Z Haut Geschlechtskr, 1967; 42: 891-894.
4. Nagy E, Meszaros C, Soralyoi I. Scrofulous lichen following BCG vaccination. Z Haut Geschlechtskr, 1972; 47: 859-862.
5. Shea CR, Imber MJ, Cropley TG et al. Granulomatous eruption after BCG vaccine immunotherapy for malignant melanoma. J Am Acad Dermatol, 1989; 21: 1119-1122.
6. Park YM, Kang H, Cho SH, Cho BK. Lichen scrofulosorum-like eruption localized to multipuncture BCG vaccination site. J Am Acad Dermatol, 1999; 41: 262-264.
7. Katoch K, Katoch VM, Natrajan M et al. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy. Int J Lepr Other Mycobact Dis, 1995; 63: 102-111.
8. Smith WC. What is the best way to use BCG to protect against leprosy: when, for whom, and how often? Int J Lepr Other Mycobact Dis, 2004; 72: 48.
9. Narang T, Kaur I, Kumar B, et al. Comparative evaluation of immunotherapeutic efficacy of BCG and Mw vaccines in patients with multibacillary leprosy. Int J Lepr Other Mycobact Dis, 2005 (in press).
10. Hebra F. Lichen scrofulosorum. In: Fagge CH and Pye-Smoth PH (eds) Diseases of the skin, vol. 2. New Sydenham Society, London,: 1868, p. 58.
11. Arora SK, Kumar B, Sehgal S. Development of a polymerase chain reaction dot-blotting system for detecting cutaneous tuberculosis. Br J Dermatol, 2000; 142: 72-76.
12. Horwitz O, Jorgensen BB. Dermatological complications of BCG. vaccination. Acta Tuberc Scand, 1956; 32: 179-194.
13. Convit J, Ulrich M. Immunotherapy and immunoprophylaxis of leprosy, Ind J Lepr, 2000; 72: 21-32.
14. Moschella SL and Cropley TG Bacillus Calmette-Guerin vaccine. In: Moschella SC and Hurley HJ (eds) Dermatology. WB Saunders, Philadelphia 1992, pp. 1082-1083.
15. Job CK, Nayar A, Narayanan JS. Electronmicroscopic study of hypopigmented lesions in leprosy. A preliminary report. Br J Dermatol, 1972; 87: 200-212.